Home / Specialties / Bone & Joint

Bone & Joint

The Diabetes Organ Nobody Talks About: Could Bone Hold the Next Treatment Breakthrough?

3D medical illustration showing the human skeleton releasing bone hormones that interact with the pancreas, muscles, and blood vessels to influence insulin sensitivity and glucose metabolism.

When most people think about diabetes, they picture the pancreas, insulin, or blood sugar. However, researchers are increasingly asking a different question: what if another organ has been quietly influencing glucose metabolism all along? Surprisingly, the answer may be the skeleton. For decades, bone was viewed primarily as the body’s …

Read More »

Diabetes and Fracture Risk: Why Bone Health Is Becoming a Bigger Clinical Concern

Bone model beside a glucose meter illustrating the connection between diabetes and fracture risk

People living with diabetes already face challenges related to blood sugar, cardiovascular disease, kidney health, and nerve damage. However, another issue is now gaining attention among healthcare professionals: bone health. Research continues to show that patients with diabetes have a higher risk of fractures, falls, and long-term mobility problems, even …

Read More »

Do GLP-1 Drugs Improve Osteoarthritis Outcomes? What New Trials Suggest About Pain and Mobility

Patient with knee osteoarthritis pain beside GLP-1 injection pens illustrating obesity-related joint treatment and mobility improvement

For many patients with obesity-related osteoarthritis, daily movement can feel like walking with a heavy backpack that never comes off. Joint pain limits exercise, reduced activity leads to more weight gain, and the cycle continues. However, new research is raising an important question: could GLP-1 therapies help break that cycle? …

Read More »

GLP-1s and Inflammatory Arthritis: What Early Signals Mean for Diabetes Care

GLP-1 injection pen next to inflamed knee joints illustrating the relationship between GLP-1 therapy and inflammatory arthritis in diabetes care

A patient with type 2 diabetes finally achieves better glycemic control on a GLP-1 receptor agonist. Weight is coming down, A1C is improving, and cardiovascular risk looks more manageable. Then an unexpected comment appears at a follow-up visit. Their joints feel better. For clinicians, moments like this raise an important …

Read More »

GLP‑1s and Bone Health: Do Incretins Protect or Put Patients at Risk?

Illustration showing a glowing skeleton, GLP‑1 medications, porous bone models, and a balance scale highlighting bone health risks.

Glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have transformed type 2 diabetes management by improving blood sugar control and promoting weight loss. Yet as clinical use grows, so does interest in how GLP‑1 medications affect skeletal health — particularly their impact on bone density, remodeling, and fracture risk. This article unpacks …

Read More »

Insulin Omission for Weight Loss in a Female Adolescent Treated With Advanced Hybrid Closed-Loop System

In a recent article published in the journal Diabetes Care, researchers from Israel reported on a case of a female adolescent with type 1 diabetes who was intentionally omitting insulin in an attempt to lose weight. The adolescent was treated with an advanced hybrid closed-loop system (AHCL), which is a …

Read More »